Comments

MiNK Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does MiNK Therapeutics (INKT) operate in?

MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

INKTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$7.54

0.365.01%

At close: -

$7.17

-0.37-4.91%

After Hours: 4:01 PM EDT

The most recent conference call was at 8:30 AM, 2 days ago Click to view past webcast

MiNK Therapeutics (INKT) Forecast

News Earnings MiNK Therapeutics (INKT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

MiNK Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:INKT | Benzinga

Explore MiNK Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INKT.

Open	$7.18
Close	$7.54
Volume / Avg.	2.28K / 7.40K
Day Range	$7.18 - $7.54
52 Wk Range	0.68 - 13.79
Market Cap	$28.44M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	2.27%
Days to Cover	10.28

Recent News

Why MiNK Therapeutics Stock Is Up 11% Monday

MiNK Therapeutics shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million.

Dylan Berman

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

Avi Kapoor

Sacks Parente Golf And 3 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed higher by more than 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.18
Close	$7.54
Volume / Avg.	2.28K / 7.40K
Day Range	$7.18 - $7.54
52 Wk Range	0.68 - 13.79
Market Cap	$28.44M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	2.27%
Days to Cover	10.28

About MiNK Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, develo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MiNK Therapeutics (INKT) stock?

You can purchase shares of MiNK Therapeutics (NASDAQ:INKT) through any online brokerage.

View our list of the best stock brokerages

Who are MiNK Therapeutics (INKT) competitors?

Other companies in MiNK Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Burning Rock Biotech (NASDAQ:BNR), Coeptis Therapeutics (NASDAQ:COEP) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).

What is the forecast, or price target, for MiNK Therapeutics (INKT) stock?

MiNK Therapeutics has a consensus price target of $14.00.

What is the current price for MiNK Therapeutics (INKT)?

The stock price for MiNK Therapeutics (NASDAQ: INKT) is $7.17 last updated May 16, 2025 at 4:01 PM EDT.

Does MiNK Therapeutics (INKT) pay a dividend?

There are no upcoming dividends for MiNK Therapeutics.

When is MiNK Therapeutics (NASDAQ:INKT) reporting earnings?

MiNK Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is MiNK Therapeutics (INKT) going to split?

There is no upcoming split for MiNK Therapeutics.

What sector and industry does MiNK Therapeutics (INKT) operate in?

MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.